CRISPR Therapeutics AG Vs. Editas Medicine Industry Stock Comparison

Sell

44

CRSP
CRISPR Therapeutics AG

Last Price:

49.41

Seasonality Move:

3.26%

Sell

40

EDIT
Editas Medicine

Last Price:

3.92

Seasonality Move:

2.24%

Sell

44

CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

The current CRISPR Therapeutics AG [CRSP] share price is $49.55. The Score for CRSP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

40

Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

The current Editas Medicine [EDIT] share price is $3.87. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

The CRISPR Therapeutics AG share price today is $49.55
The current trend is relatively stagnant and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

The Editas Medicine share price today is $3.87
The current trend is relatively stagnant and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.

CRSP Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.56	Sell
Relative Strength Index (14 RSI):	54.66	Buy
Chaikin Money Flow:	-1124988	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(45.74 - 49.2)	Buy
Bollinger Bands (100):	(48.75 - 58.61)	Sell

EDIT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.13	Sell
Relative Strength Index (14 RSI):	47.5	Sell
Chaikin Money Flow:	-2434195	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.61 - 3.97)	Buy
Bollinger Bands (100):	(4.12 - 5.64)	Sell

CRSP Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	47.24	Buy
20-day SMA:	47.24	Buy
50-day SMA:	50.94	Sell
200-day SMA:	60.86	Sell
8-day EMA:	47.92	Buy
20-day EMA:	47.76	Buy
50-day EMA:	50.17	Sell
200-day EMA:	56.34	Sell

EDIT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.79	Buy
20-day SMA:	3.75	Buy
50-day SMA:	4.44	Sell
200-day SMA:	6.62	Sell
8-day EMA:	3.8	Buy
20-day EMA:	3.85	Buy
50-day EMA:	4.27	Sell
200-day EMA:	6.06	Sell

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.01 per share, a decrease this year of $2.74 per share, and an increase next year of $0.41 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.68 per share, and an increase next year of $0.17 per share.

CRISPR Therapeutics AG Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):